Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
AASLD, abetting, ACA, admission, amenable, Asian, ASN, atherosclerotic, attack, ATTRv, axonal, backbone, begun, buildup, capture, Cas, CDE, cessation, child, Clustered, Cohen, composed, conclusion, confirmatory, construct, constructing, construction, curb, cybersecurity, default, Defeasance, dementia, DHC, EASL, echocardiography, editing, effectuated, eGFR, ESSENCE, ethical, filtration, finite, Fisher, geopolitical, glomerular, hearing, HRQoL, ICAV, immunoglobulin, ineffective, interior, Interspaced, intolerance, IRA, IRC, juvenile, land, lawsuit, leaseback, LLOQ, loading, lt, MAA, marker, meaningful, median, mesyl, Metagenomi, Midland, monetization, monetize, MsPA, NA, Nephrology, neurodegeneration, neurofilament, Oceanside, Olpasiran, Owner, Oxford, oxygen, Palindromic, Parexel, pegozafermin, Pendency, phosphoramidate, Pledge, PNC, pollution, prodromal, proinflammatory, proteinuria, pump, Quantification, readout, real, redesign, regained, repaid, reveal, revert, Robert, Russia, Russian, Silence, stratified, Successor, Sudberry, synergistic, Task, TCJA, tension, Thermo, throat, UBSCM, Ukraine, undesirable, undeveloped, ventricular, versatile, warehouse, zilganersen
Removed:
abdomen, absent, accessible, activating, activator, adaptation, adenine, adequately, adipose, adolescence, adrenal, advice, aerosol, aging, agreed, aim, altering, ameliorate, amino, amortizable, amortizing, analytical, androgen, anemia, ANVISA, Arimoclomol, ATL, Atlantic, attach, autosomal, batch, Biotech, bodily, break, breast, Brexit, buying, capability, cascade, catch, centralized, centronuclear, chaperone, characterizing, CHDI, chelation, chromosome, CNM, color, commonly, competitively, concept, conjugate, consisting, converting, copied, cytosine, damaged, danvatirsen, dark, degradation, degrade, deoxyribonucleic, dominant, dosed, double, dozen, durvalumab, Dynacure, Dynamin, efficient, Empirico, encoded, enhancing, escalation, essential, ethyl, exchanged, expensed, eye, feet, Figure, foresee, founder, founding, frame, frederick, gap, gapmer, GCGR, gemcabene, genomic, gland, glucagon, glucose, guanine, Illustration, initiate, insignificant, intact, interact, interfering, intermedia, interrupt, intraocular, intravenously, invoice, Janssen, ladder, landscape, largely, larynx, leave, lifespan, light, lncRNA, Ludwig, lung, macula, manageable, manifestation, medicinal, messenger, metabolize, metastatic, modulation, MOE, muto, myeloma, myopathy, naturally, neck, night, nonconvertible, NTDT, numerical, occurring, offered, oncology, opposing, Orphazyme, overactivity, painful, pairing, pancreatic, parallel, participate, photoreceptor, pigmentosa, polymerase, PPD, prepared, PRIME, processing, proliferation, prompt, properly, ProQR, prostate, reaching, reading, reassessed, recording, redemption, referendum, refund, relation, removing, repeatedly, resemble, retina, retinal, retrospectively, rhodopsin, ribosome, RNAP, robustly, RP, SAS, scheduling, Science, selecting, selectivity, sense, separated, separation, signal, skeletal, stored, strand, structure, template, thalassemia, thymine, timeline, tone, toxicity, trachea, transcribed, transcription, transducer, transitioned, translate, tumor, twenty, twisted, UK, uncoiling, undruggable, unintended, unique, uniquely, unwanted, updated, uptake, virtually, visual, vote, weakly, write
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Exhibit 10.1
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 10.16 Exhibit 10.16
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.80 Exhibit 10.80
- 10.81 Exhibit 10.81
- 14 Exhibit 14
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- Download Excel data file
- View Excel data file
Related press release
Associated IONS transcripts
IONS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-71911, 333-90811, 333-38844, 333-71116, 333-71176, 333-89066, 333-89626, 333-128156, 333-130639, 333-134380, 333-141447, 333-151076, 333-188407, 333-217422 and 333-242382) and in the related Prospectuses, as applicable, and in the Registration Statements on Form S-8 (Nos. 333-05825, 333-55683, 333-40336, 333-59296, 333-91572, 333-106859, 333-116962, 333-125911, 333-133853, 333-142777, 333-151996, 333-160269, 333-168674, 333-176136, 333-184788, 333-190408, 333-207900, 333-219801, 333-233143, 333-242386, 333-251855, and 333-258503) of Ionis Pharmaceuticals, Inc. of our reports dated February 22, 2023, with respect to the consolidated financial statements of Ionis Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Ionis Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2022.
/s/ ERNST & YOUNG LLP | |
San Diego, California | |
February 22, 2023 |